{"id":814273,"date":"2024-08-21T13:05:27","date_gmt":"2024-08-21T11:05:27","guid":{"rendered":"https:\/\/bigman.to\/en\/product\/organon-pregnyl-5000-1-amp-1x-5000-iu-expiration\/"},"modified":"2026-08-13T22:09:03","modified_gmt":"2026-08-13T20:09:03","slug":"organon-pregnyl-5000-1-amp-1x-5000-iu-expiration","status":"publish","type":"product","link":"https:\/\/bigman.to\/lv\/produkts\/organon-pregnyl-5000-1-amp-1x-5000-iu-expiration\/","title":{"rendered":"Organon Pregnyl 5000 1 amp (1x 5000 IU) DER\u012aGUMA TERMI\u0145A BEIGAS"},"content":{"rendered":"<h2>HCG - cilv\u0113ka horiongonadotrop\u012bns - Pregnyl<\/h2><p>\u0160is nestero\u012bds medikaments ir popul\u0101ra izv\u0113le sportistu vid\u016b. HCG ir dabisks hormons, ko ra\u017eo placenta un ieg\u016bst no gr\u016btnie\u010du ur\u012bna. Lai gan tas nav v\u012brie\u0161u hormons, tas \u013coti l\u012bdzin\u0101s dabiskajam LH (Luetiniz\u0113jo\u0161ajam hormonam), izraisot testosterona ra\u017eo\u0161anu v\u012brie\u0161iem, iedarbojoties uz s\u0113klinieku Leidiga \u0161\u016bn\u0101m. S\u0101kotn\u0113ji HCG tika izstr\u0101d\u0101ts, lai \u0101rst\u0113tu oln\u012bcu darb\u012bbas trauc\u0113jumus sieviet\u0113m, ta\u010du to izmanto ar\u012b v\u012brie\u0161i, lai paaugstin\u0101tu testosterona l\u012bmeni, kas bie\u017ei vien ir nom\u0101kts ilgsto\u0161as stero\u012bdu lieto\u0161anas d\u0113\u013c. Lielu stero\u012bdu devu lieto\u0161ana var maldin\u0101t hipotal\u0101mu, v\u0101jinot t\u0101 sign\u0101lus s\u0113kliniekiem un izraisot s\u0113klinieku atrofiju. HCG pal\u012bdz uztur\u0113t sign\u0101lu uz s\u0113kliniekiem, nov\u0113r\u0161ot \u0161o st\u0101vokli. P\u0113c injection lieto\u0161anas HCG strauji paaugstina testosterona l\u012bmeni serum\u0101, iedarb\u012bba ir paman\u0101ma divu stundu laik\u0101 un maksimums sasniedzams p\u0113c div\u0101m l\u012bdz \u010detr\u0101m dien\u0101m. \u0160\u012b terapija ir efekt\u012bva s\u0113klinieku atrofijas nov\u0113r\u0161anai un plazmas testosterona l\u012bme\u0146a optimiz\u0113\u0161anai, jo \u012bpa\u0161i treni\u0146u f\u0101z\u0113s. Da\u017eiem sportistiem, kombin\u0113jot HCG ar stero\u012bdiem, iev\u0113rojami uzlabojas sp\u0113ks un izm\u0113rs, jo paaugstin\u0101s dab\u012bgo androg\u0113nu l\u012bmenis. Optim\u0101ls re\u017e\u012bms nav noteikts, bet v\u0113lamajiem rezult\u0101tiem ieteicams lietot devas no 1000 l\u012bdz 2000 SV ned\u0113\u013c\u0101, cikliem nep\u0101rsniedzot tr\u012bs ned\u0113\u013cas, p\u0113c kur\u0101m seko m\u0113nesis p\u0101rtraukuma. Piem\u0113ram, HCG var lietot divas l\u012bdz tr\u012bs ned\u0113\u013cas cikla vid\u016b un atkal cikla beig\u0101s. Ilgsto\u0161a lieto\u0161ana var kav\u0113t organisma dabisko gonadotrop\u012bnu veido\u0161anos, t\u0101d\u0113j\u0101di uzsverot \u012bsu ciklu noz\u012bmi. Iesp\u0113jam\u0101s blakuspar\u0101d\u012bbas ir ginekomastija, \u0161\u0137idruma aizture, paaugstin\u0101ts libido, garast\u0101vok\u013ca sv\u0101rst\u012bbas, galvass\u0101pes un paaugstin\u0101ts asinsspiediens. HCG var palielin\u0101t v\u012brie\u0161u androg\u0113nu l\u012bmeni l\u012bdz 400%, bet tas var ar\u012b palielin\u0101t estrog\u0113nu l\u012bmeni, radot ginekomastijas risku, lietojot liel\u0101kas devas. Citas zi\u0146ot\u0101s blakuspar\u0101d\u012bbas ir slikta d\u016b\u0161a un vem\u0161ana. Nav zi\u0146ots par HCG p\u0101rdoz\u0113\u0161anas gad\u012bjumiem, k\u0101 ar\u012b par aknu vai nieru darb\u012bbas trauc\u0113jumiem. Lai gan past\u0101v\u0113ja ba\u017eas par HCG iesp\u0113jamu HIV p\u0101rn\u0113s\u0101\u0161anu, pa\u0161reiz\u0113jie pier\u0101d\u012bjumi \u0161o iesp\u0113ju noliedz. T\u0101d\u0113j\u0101di sportisti var izmantot HCG, lai mazin\u0101tu probl\u0113mas, ko rada p\u0113k\u0161\u0146a stero\u012bdu lieto\u0161anas p\u0101rtrauk\u0161ana. Turkl\u0101t HCG parasti netiek atkl\u0101ts stero\u012bdu testos, t\u0101p\u0113c tas ir pievilc\u012bgs sportistiem, kuriem j\u0101veic narkotiku p\u0101rbaudes. P\u0113c sajauk\u0161anas HCG, ievadot intramuskul\u0101ri, nepiecie\u0161ams uzglab\u0101t ledusskap\u012b, un t\u0101 der\u012bguma termi\u0146\u0161 ir aptuveni 10 ned\u0113\u013cas. \u0100rsti to bie\u017ei izraksta pacientiem, kuriem ir hipogonadisma simptomi, lai gan melnaj\u0101 tirg\u016b tas ir reti sastopams.<\/p><h3>Pregnyl un gr\u016btniec\u012bba:<\/h3><p>Pregn\u012bls jeb cilv\u0113ka horiongonadotrop\u012bns (hCG) ir \u013coti att\u012br\u012bts \u0161\u0137\u012bdums, kas ieg\u016bts no gr\u016btnie\u010du ur\u012bna. Ievad\u012bts intramuskul\u0101ri, tas imit\u0113 fiziolo\u0123isko LH piepl\u016bdumu, kas nepiecie\u0161ams ovul\u0101cijas izrais\u012b\u0161anai. P\u0101riem parasti tiek ieteikts 48 stundas p\u0113c LH uzpl\u016bduma veikt ikdienas dzimumaktu. J\u016bsu \u0101rsts sniegs nor\u0101d\u012bjumus par dzimumakta laika noteik\u0161anu vai noteikt\u0101s situ\u0101cij\u0101s ieteiks m\u0101ksl\u012bg\u0101s apaug\u013co\u0161anas proced\u016bras, lai optimiz\u0113tu gr\u016btniec\u012bbas izredzes.<\/p><h3>Humegon un Pregnyl lieto\u0161ana<\/h3><p>Humegon tiek ievad\u012bts intramuskul\u0101ri, parasti s\u0113\u017eamviet\u0101, jo t\u0101 olbaltumvielu \u012bpa\u0161\u012bbas ne\u013cauj to lietot iek\u0161\u0137\u012bgi. Injekcijas parasti s\u0101k veikt menstru\u0101l\u0101 cikla pirmaj\u0101s piec\u0101s dien\u0101s un var turpin\u0101t katru dienu 7 l\u012bdz 12 dienas, piel\u0101gojot devu atkar\u012bb\u0101 no individu\u0101l\u0101s atbildes reakcijas uz \u0101rst\u0113\u0161anu. \u0100rstiem ir ierasts main\u012bt devas un grafiku \u0101rst\u0113\u0161anas ciklu laik\u0101. Pregnyl (horiongonadotrop\u012bns injection, USP) tiek ievad\u012bts ar\u012b intramuskul\u0101ri, tikl\u012bdz \u0101rsts uzskata, ka ir sasniegti atbilsto\u0161ie stimul\u0101cijas krit\u0113riji. Ja tiek nov\u0113rota p\u0101rm\u0113r\u012bga atbildes reakcija, injection lieto\u0161anu var atlikt.<\/p><h3>\u0100rst\u0113\u0161anas ilgums<\/h3><p>Ja ie\u0146em\u0161ana nenotiek, Humegon un Pregnyl var atkal noz\u012bm\u0113t n\u0101kamajos menstru\u0101ciju ciklos. Tom\u0113r pacient\u0113m nedr\u012bkst veikt sec\u012bgus \u0101rst\u0113\u0161anas ciklus; process ir individualiz\u0113ts. Terapiju var pagarin\u0101t l\u012bdz se\u0161iem cikliem, pirms tiek izv\u0113rt\u0113tas alternat\u012bvas iesp\u0113jas.<\/p><h3>Efektivit\u0101tes nov\u0113rt\u0113\u0161ana<\/h3><p>Ovul\u0101cijas laik\u0101 oln\u012bc\u0101s palielin\u0101s progesterona l\u012bmenis, ko var izm\u0113r\u012bt, veicot asins anal\u012bzi aptuveni septi\u0146as dienas p\u0113c ovul\u0101cijas. Ja gr\u016btniec\u012bba nenotiek, m\u0113ne\u0161reizes, visticam\u0101k, iest\u0101sies 14 dienas p\u0113c hCG injection; v\u0113l\u0101k gr\u016btniec\u012bbu var apstiprin\u0101t ar asins anal\u012bzi, un t\u0101s norisi nov\u0113rt\u0113 ar ultrasonogr\u0101fiju.<\/p><h3>Uzraudz\u012bbas noz\u012bme<\/h3><p>R\u016bp\u012bga uzraudz\u012bba ir \u013coti svar\u012bga, lai p\u0101rvald\u012btu \u0101rst\u0113\u0161anu un mazin\u0101tu blakuspar\u0101d\u012bbas, izmantojot gan ikdienas asins anal\u012bzes, lai sekotu l\u012bdzi estrog\u0113nu l\u012bmenim, gan ultraska\u0146as att\u0113lveido\u0161anu, lai vizualiz\u0113tu folikulu att\u012bst\u012bbu. \u0160\u0101da prakse nodro\u0161ina savlaic\u012bgu \u0101rst\u0113\u0161anas piel\u0101go\u0161anu, ja nepiecie\u0161ams.<\/p><h3>Blakuspar\u0101d\u012bbas un riski, kas saist\u012bti ar \u0101rst\u0113\u0161anu<\/h3><p>Gan Humegon, gan Pregnyl var izrais\u012bt da\u017e\u0101das blakuspar\u0101d\u012bbas - no viegl\u0101m l\u012bdz smag\u0101m, t\u0101p\u0113c ir svar\u012bgi apspriest \u0161os riskus ar \u0101rstu. Injekcijas var izrais\u012bt \u012bslaic\u012bgu piet\u016bkumu, kairin\u0101jumu un s\u0101pes injekcijas viet\u0101. Citas iesp\u0113jam\u0101s reakcijas ir galvass\u0101pes, diskomforts v\u0113der\u0101 un oln\u012bcu palielin\u0101\u0161an\u0101s. Par visiem simptomiem pazi\u0146ojiet savam \u0101rstam, lai nov\u0113rt\u0113tu un potenci\u0101li kori\u0123\u0113tu \u0101rst\u0113\u0161anu. Pregnyl injekcijas var l\u012bdz\u012bgi izrais\u012bt s\u0101pes injection ievad\u012b\u0161anas viet\u0101, k\u0101 ar\u012b var izrais\u012bt galvass\u0101pes, irritabilumu, trauksmi, nogurumu un t\u016bsku. Viena no b\u016btisk\u0101m ba\u017e\u0101m saist\u012bb\u0101 ar neaugl\u012bbas z\u0101l\u0113m ir daudzdzim\u0161anas risks; aptuveni 80% gr\u016btniec\u012bbas p\u0113c \u0101rst\u0113\u0161anas beidzas ar viendzim\u0161anu, lai gan bie\u017ei sastopami dv\u012bn\u012b\u0161i un var piedzimt vair\u0101k nek\u0101 tr\u012bs b\u0113rni. Pirms \u0101rst\u0113\u0161anas uzs\u0101k\u0161anas \u0101rstam j\u0101apsprie\u017e \u0161is risks. Pirms terapijas uzs\u0101k\u0161anas p\u0101rliecinieties, ka ar savu \u0101rstu apspried\u0101t jebk\u0101das blakuspar\u0101d\u012bbas vai ba\u017eas.<\/p><h3>Humegon (menotrop\u012bni injekcij\u0101m, USP) efektivit\u0101te<\/h3><p>Humegon var efekt\u012bvi izrais\u012bt ovul\u0101ciju sieviet\u0113m ar neregul\u0101riem cikliem vai anovul\u0101ciju. Tom\u0113r efektivit\u0101tes r\u0101d\u012bt\u0101ji at\u0161\u0137iras atkar\u012bb\u0101 no neaugl\u012bbas iemesliem, piem\u0113ram, cauru\u013cvadu st\u0101vok\u013ca, spermas kvalit\u0101tes un pacienta vecuma. Ja \u0101rst\u0113\u0161anas ar Humegon laik\u0101 gr\u016btniec\u012bba neiest\u0101jas, J\u016bsu \u0101rsts izp\u0113t\u012bs papildu iesp\u0113jas.<\/p><h3>Secin\u0101jums<\/h3><p>\u0160odien, izmantojot t\u0101das neaugl\u012bbas \u0101rst\u0113\u0161anas metodes k\u0101 Humegon un Pregnyl (horiongonadotrop\u012bns injection, USP), ir piedzimu\u0161i daudzi veseli b\u0113rni. Lai sa\u0146emtu papildu inform\u0101ciju par \u0161\u012bm z\u0101l\u0113m, konsult\u0113jieties ar savu \u0101rstu.<br>\n<!-- Potentially malicious script removed by Stanektech Unhacker --><\/p>","protected":false},"excerpt":{"rendered":"<p>Discover Organon Pregnyl 5000, a powerful human chorionic gonadotropin (HCG) injection designed to stimulate natural testosterone production in men and assist in ovulation for women. Ideal for athletes and those seeking hormonal balance, it requires proper administration and guidance from a healthcare professional for optimal results.<\/p>","protected":false},"featured_media":826868,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[710],"product_tag":[527,490,491,530,486,526],"class_list":{"0":"post-814273","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-hcg-human-chorionic-gonadotropic","7":"product_tag-antiesterogen","8":"product_tag-for-men","9":"product_tag-for-women","10":"product_tag-hcg","11":"product_tag-injectable","12":"product_tag-pct","13":"pa_brand-organon","15":"first","16":"outofstock","17":"sale","18":"shipping-taxable","19":"purchasable","20":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/bigman.to\/lv\/wp-json\/wp\/v2\/product\/814273","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bigman.to\/lv\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/bigman.to\/lv\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/bigman.to\/lv\/wp-json\/wp\/v2\/comments?post=814273"}],"version-history":[{"count":11,"href":"https:\/\/bigman.to\/lv\/wp-json\/wp\/v2\/product\/814273\/revisions"}],"predecessor-version":[{"id":835855,"href":"https:\/\/bigman.to\/lv\/wp-json\/wp\/v2\/product\/814273\/revisions\/835855"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bigman.to\/lv\/wp-json\/wp\/v2\/media\/826868"}],"wp:attachment":[{"href":"https:\/\/bigman.to\/lv\/wp-json\/wp\/v2\/media?parent=814273"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/bigman.to\/lv\/wp-json\/wp\/v2\/product_brand?post=814273"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/bigman.to\/lv\/wp-json\/wp\/v2\/product_cat?post=814273"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/bigman.to\/lv\/wp-json\/wp\/v2\/product_tag?post=814273"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}